Skip to main navigation Skip to search Skip to main content

Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome (NeuroMolecular Medicine, (2021), 23, 4, (561-571), 10.1007/s12017-021-08651-5)

Tomer Illouz, Arya Biragyn, Milana Frenkel-Morgenstern, Orly Weissberg, Alessandro Gorohovski, Eugene Merzon, Ilan Green, Florencia Iulita, Lisi Flores-Aguilar, Mara Dierssen, Ilario De Toma, Hefziba Lifshitz, Stylianos E. Antonarakis, Eugene Yu, Yann Herault, Marie Claude Potier, Alexandra Botté, Randall Roper, Benjamin Sredni, Ronit SaridJacqueline London, William Mobley, Andre Strydom, Eitan Okun

Research output: Contribution to journalComment/debate

Abstract

A correction to this paper has been published: https://doi.org/10.1007/s12017-021-08657-z.

Original languageEnglish
Pages (from-to)572-573
Number of pages2
JournalNeuroMolecular Medicine
Volume23
Issue number4
Early online date4 May 2021
DOIs
StatePublished - Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Neurology
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome (NeuroMolecular Medicine, (2021), 23, 4, (561-571), 10.1007/s12017-021-08651-5)'. Together they form a unique fingerprint.

Cite this